Akarx Inc Drug Patent Portfolio
Akarx Inc owns 1 orange book drug protected by 3 US patents Given below is the list of Akarx Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638536 | 2-Acylaminothiazole derivative or salt thereof | 28 Jul, 2027 | Active |
| US8338429 | 2-acylaminothiazole derivative or salt thereof | 30 Jun, 2023 | Expired |
| US8765764 | 2-acylaminothiazole derivative or salt thereof | 15 Jan, 2023 | Expired |
Latest Legal Activities on Akarx Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Akarx Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Term Extension Certificate
Critical
| 08 Jan, 2024 | US7638536 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 26 Dec, 2023 | US7638536 |
| Requirement for information sent under 37 CFR 1.750 | 08 Dec, 2023 | US7638536 |
| Notice of Final Determination -Eligible | 16 Nov, 2023 | US7638536 |
|
FDA Final Eligibility Letter
Critical
| 14 Nov, 2023 | US7638536 |
| transaction for FDA Determination of Regulatory Review Period | 06 Feb, 2023 | US7638536 |
| transaction for FDA Determination of Regulatory Review Period | 02 Feb, 2023 | US7638536 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 02 Feb, 2023 | US7638536 |
|
Interim Patent Term Extension Granted
Critical
| 11 Jan, 2023 | US7638536 |
|
PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Critical
| 09 Jan, 2023 | US7638536 |
|
Terminal Disclaimer Filed
Critical
| 09 Jan, 2023 | US7638536 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Dec, 2021 | US8765764 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Jun, 2021 | US7638536 |
| Second letter to regulating agency to determine regulatory review period | 26 Apr, 2021 | US7638536 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Jun, 2020 | US8338429 |
Akarx Inc's Family Patents
Akarx Inc Drug List
Given below is the complete list of Akarx Inc's drugs and the patents protecting them.
1. Doptelet
Doptelet is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638536 | 2-Acylaminothiazole derivative or salt thereof |
28 Jul, 2027
(1 year, 11 months from now)
| Active |
| US8338429 | 2-acylaminothiazole derivative or salt thereof |
30 Jun, 2023
(2 years ago)
| Expired |
| US8765764 | 2-acylaminothiazole derivative or salt thereof |
15 Jan, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doptelet's drug page